Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-11
2006-07-11
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S529000, C424S535000, C424S548000, C514S002600, C514S04400A, C530S300000, C530S324000
Reexamination Certificate
active
07074767
ABSTRACT:
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and another unique peptide having 21 amino acids and connected with an oligo-nucleotide through a diphosphodiester or diphosphodithioate ester linkage. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260 nm/280 nm and 1.359 at 260 nm/230 nm.
REFERENCES:
patent: 5807839 (1998-09-01), Hirschman
patent: 5807840 (1998-09-01), Hirschman
patent: 5849196 (1998-12-01), Kochel
patent: 5902786 (1999-05-01), Bregman
Cooke, Stanford B., Upper Respiratory Viral Manifestations, Clinical Symposium on Viral Diseases Demonstrating the Anti-viral Biotic Properties of the Drug Reticulose (Symposium), Sep. 1960, Miami Beach, Florida, pp. 25-32.
Kosaka, K and Shimada, Y., Infectious Hepatitis, Symposium, pp. 61-74, 1960.
Kuckku, Morris E., Herpetic Diseases, Symposium, pp. 7-13, 1960.
Medoff, Lawrence R., Infectious Mononucleosis, Symposium, pp. 33-37, 1960.
Plucinski, Stanisloff J., Suspected Viral Varieties, Symposium, pp. 53-59, 1960.
Reynolds, Margaret R., Generalized Vaccinia, Symposium, pp. 5-6, 1960.
Schaeffer, Oden A., Influenza, Symposium, pp. 15-21, 1960.
Seydel, Frank, Epidemic, Asian Influenza, Symposium, pp. 23-24, 1960.
Anderson, Robert H., Encephalitis, Symposium, pp. 39-52, 1960.
Anderson, Robert H. and Thompson, Ralph M., Treatment of Viral Syndrome with a Lipoprotein-Nucleic Acid Compound (Reticulose), A Report of five Cases, Virginia Medical Monthly, 84: 347-353, 1957.
Reynolds, Margaret R., Generalized Vaccinia Successfully Treated With Lipoprotein-Nucleic Acid Complex (Reticulose), Archives of Pediatrics, 77:421-422, 1960.
Kozima, Fumio, Osawa, Mitsuo and Oyama, Mitsuko, Animal Tests on Reticulose (“Key”), Kensan Report No. Sho 43-22, Sep. 4, 1968.
Wegryn, Stanley P., Marks, Robert A. and Baugh, John R., Herpes Gestationis, A Report of 2 Cases, American Journal of Obstetrics and Gynecology, 79:812-814, 1960.
Catterall, R.A., Lumpur, Kuala, A New Testament of Herpes Zoster, Vaccinia And Chicken Pox, J. Roy. Coll. Gen. Practit., 1970, 19, 182.
Chinnici, Angelo A., Reticulose in Treatment Aids patients, Personal Communication to William Bregman, Jul. 6, 1992.
Cott, Rafael A., Summary of 11 Cases of Viral Infections Treated with Reticulose, Private Communication with Advance Viral Research Corp., 1992.
Cohen, Matthew, The Efficacy of a Peptide-Nucleic Acid Solution (Reticulose) for the Treatment of Hepatitis A and Hepatitis B—a Preliminary Controlled Human Clinical Trial, J. Roy. Soc. Health, Dec. 1992, 266-270.
Mundschenk, David D., In Vitro Antiviral Activity of Reticulose vs Influenaz A, Personal Communication with William Bregman, May 1, 1990.
Resnick, Lionel, Anti-HIV in Vitro Activity of Two Samples of Peptide-nucleic Acid Solution, Personal Communication with Dr. Bernard Friedland, Dec. 22, 1989.
Friedland, Bernard, In Vitro Antiviral Activity of a Peptide-Nucleic Acid Solution Against the Human Immunodeficiency Virus and Influenza A Virus, J. Roy. Soc. Health, Oct. 1991, 170-171.
Brazier, Anne D., Method for in Vitro Antiviral Evaluation Human Immunodeficiency Virus (HIV), Personal Communication with Dr. Bernard Friedland, Oct. 4, 1989.
Behbehani, Abbas M., Haberman Sol and Race, George J, The Effect of Reticulose on Viral Infections of Experimental Animals, Southern Medical Journal, Feb. 1962, 185-188.
Treatment of Viral Diseases with A Lipo-protein Nucleic Acid Complex (Reticulose)—A Clinical Study, Scientific Exhibit: Virginia State Medical Society Meeting, Washington, D.C., Nov. 1957.
Kempe, Henry C., Fulginiti, Vincent A., and Vincent, Leone St., Failure to Demonstrate Antiviral Activity of Reticulose, Diseases of Children, vol. 103, No. 5, 655-657, 1962.
Sanders, Murray, Controlled Animal Studies with Reticulose Illustrating the Interference of Lipoprotein-Nucleic Acid Complex in the Experimental Animal Infected with Human Pathogenic Viral Entities, Southern Medical Association Scientific Exhibit, Dallas, Texas, Nov. 1961.
Friedland Bernard
Hirschman Shalom Z.
Taraporewala Irach B.
Advanced Viral Research Corp.
Jones Day
Witz Jean C.
LandOfFree
Preparation of a therapeutic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of a therapeutic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of a therapeutic composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567591